Cambridge, United Kingdom

James Edward Stewart Duffy

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Edward Stewart Duffy. Retrieved from https://idiyas.com/inventor/james-edward-stewart-duffy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7



Average Co-Inventor Count = 12.7

ph-index = 2

Forward Citations = 22(Granted Patents)


Location History:

  • Cambridgehire, GB (2012)
  • Cambridge, GB (2012 - 2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of James Edward Stewart Duffy

Introduction

James Edward Stewart Duffy is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds.

Latest Patents

Duffy holds three patents, with his latest inventions focusing on quinolinone derivatives as PARP and TANK inhibitors. These compounds are designed to serve as PARP inhibitors and are included in pharmaceutical compositions that utilize specific formulas, where R, n, m, and X have defined meanings.

Career Highlights

Duffy is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work has been instrumental in advancing therapeutic options for various medical conditions.

Collaborations

Throughout his career, Duffy has collaborated with esteemed colleagues, including Jorge Eduardo Vialard and Patrick René Angibaud. These partnerships have contributed to the success of his innovative projects.

Conclusion

James Edward Stewart Duffy's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…